LanZhou Foci Pharmaceutical Co.,Ltd.
Символ: 002644.SZ
SHZ
7.47
CNYПазарна цена днес
64.5010
Съотношение P/E
-4.5151
Коефициент PEG
3.81B
MRK Cap
- 0.01%
Доходност на DIV
LanZhou Foci Pharmaceutical Co.,Ltd. (002644-SZ) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1413.19 | 406 | 398.5 | 374.9 | |||||||||||||||||
balance-sheet.row.short-term-investments | -70.42 | -15.8 | 2 | -10.4 | |||||||||||||||||
balance-sheet.row.net-receivables | 2046.86 | 441.8 | 526.5 | 390.8 | |||||||||||||||||
balance-sheet.row.inventory | 1526.12 | 369.7 | 350.4 | 258.8 | |||||||||||||||||
balance-sheet.row.other-current-assets | 74.04 | 21.3 | 15.7 | 10 | |||||||||||||||||
balance-sheet.row.total-current-assets | 5060.22 | 1238.9 | 1291.1 | 1034.6 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 4211.94 | 1061.8 | 1066.8 | 1091.6 | |||||||||||||||||
balance-sheet.row.goodwill | 26.96 | 9 | 4.5 | 4.5 | |||||||||||||||||
balance-sheet.row.intangible-assets | 320.66 | 79.6 | 76.8 | 72 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 347.63 | 88.6 | 81.3 | 76.4 | |||||||||||||||||
balance-sheet.row.long-term-investments | 335.99 | 79.9 | 66.7 | 82.1 | |||||||||||||||||
balance-sheet.row.tax-assets | 205.41 | 53.6 | 52.4 | 51.1 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 54.24 | 5.3 | 28.4 | 16.2 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 5155.21 | 1289.2 | 1295.5 | 1317.5 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 10215.43 | 2528.1 | 2586.6 | 2352.1 | |||||||||||||||||
balance-sheet.row.account-payables | 1338.65 | 310.4 | 311 | 214.3 | |||||||||||||||||
balance-sheet.row.short-term-debt | 98.74 | 24.7 | 13.8 | 14.7 | |||||||||||||||||
balance-sheet.row.tax-payables | 130.95 | 35.1 | 69.4 | 47.6 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 14.55 | 1.3 | 0.5 | 0.8 | |||||||||||||||||
Deferred Revenue Non Current | 1056.95 | 261 | 278.2 | 295 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 10.03 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 19.4 | 5.8 | 110.9 | 4.5 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1174.53 | 292 | 322.1 | 349.8 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 3.23 | 1.3 | 0.5 | 0.8 | |||||||||||||||||
balance-sheet.row.total-liab | 3126.08 | 759.7 | 852.6 | 724.6 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 2042.63 | 510.7 | 510.7 | 510.7 | |||||||||||||||||
balance-sheet.row.retained-earnings | 3119.21 | 776.2 | 746.9 | 654.5 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1237.35 | 158.4 | 152 | 143.6 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 605.87 | 300.1 | 305.8 | 305.8 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 7005.06 | 1745.4 | 1715.4 | 1614.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 10215.43 | 2528.1 | 2586.6 | 2352.1 | |||||||||||||||||
balance-sheet.row.minority-interest | 84.28 | 23.1 | 18.6 | 12.9 | |||||||||||||||||
balance-sheet.row.total-equity | 7089.35 | 1768.4 | 1734 | 1627.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 10215.43 | - | - | - | |||||||||||||||||
Total Investments | 265.57 | 64.1 | 68.7 | 71.7 | |||||||||||||||||
balance-sheet.row.total-debt | 113.29 | 26 | 14.4 | 15.5 | |||||||||||||||||
balance-sheet.row.net-debt | -1299.9 | -380 | -382.1 | -359.4 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 58.12 | 68.1 | 105.9 | 93.5 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 3.63 | 52.5 | 49.5 | 48.6 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0.2 | 1 | 0.2 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -0.2 | -1 | -0.2 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 66.85 | -82.3 | -112.2 | -117 | |||||||||||||||||
cash-flows.row.account-receivables | 59.5 | 59.5 | -210.1 | -66.8 | |||||||||||||||||
cash-flows.row.inventory | -7.3 | -7.3 | -91.7 | -0.8 | |||||||||||||||||
cash-flows.row.account-payables | 0 | -134.7 | 188.6 | -49.5 | |||||||||||||||||
cash-flows.row.other-working-capital | 14.64 | 0.2 | 1 | 0.2 | |||||||||||||||||
cash-flows.row.other-non-cash-items | -71.03 | 27.4 | 29.1 | -13.2 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 57.56 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -8.98 | -22.5 | -41.5 | -32.8 | |||||||||||||||||
cash-flows.row.acquisitions-net | -15.45 | -15.5 | 3.9 | 74.1 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 8.95 | -6 | -2.1 | -3.9 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 7.98 | 8 | -3.9 | 38.1 | |||||||||||||||||
cash-flows.row.other-investing-activites | -15.17 | 1.8 | 0.8 | -32.8 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -22.66 | -34.2 | -42.8 | 42.6 | |||||||||||||||||
cash-flows.row.debt-repayment | -22.59 | -21.5 | -14.2 | -35.3 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.5 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | -1.65 | -27.9 | -5.1 | -61.4 | |||||||||||||||||
cash-flows.row.other-financing-activites | -11.1 | -1.3 | 3.9 | 3.3 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -50.87 | -25 | -15.5 | -93.4 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 25.84 | 0.7 | 0.7 | -0.2 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 9.86 | 7.2 | 14.8 | -39.1 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1376.43 | 396.3 | 387.7 | 372.9 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1366.56 | 389.1 | 372.9 | 412 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 57.56 | 65.7 | 72.4 | 11.9 | |||||||||||||||||
cash-flows.row.capital-expenditure | -8.98 | -22.5 | -41.5 | -32.8 | |||||||||||||||||
cash-flows.row.free-cash-flow | 48.58 | 43.2 | 30.9 | -21 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1130.07 | 1163.1 | 1019.2 | 817.6 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 765.41 | 801.8 | 733 | 594.5 | |||||||||||||||||
income-statement-row.row.gross-profit | 364.66 | 361.3 | 286.2 | 223.1 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 31.51 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 17.15 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 154.39 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -2.01 | -1.6 | -9.7 | 24.4 | |||||||||||||||||
income-statement-row.row.operating-expenses | 262.09 | 262 | 129.4 | 134.6 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 1027.5 | 1063.8 | 862.3 | 729 | |||||||||||||||||
income-statement-row.row.interest-income | 2.93 | 5.4 | 7.5 | 10.2 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 1.2 | 0.7 | 0.9 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 154.39 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -2.01 | -1.6 | -12.4 | -1.5 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -2.01 | -1.6 | -9.7 | 24.4 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -2.01 | -1.6 | -12.4 | -1.5 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 1.2 | 0.7 | 0.9 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 40.06 | 52.5 | 62.2 | 32.2 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 112.68 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 72.62 | 83.3 | 139.4 | 112.4 | |||||||||||||||||
income-statement-row.row.income-before-tax | 70.6 | 81.6 | 127 | 110.8 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 11.28 | 13.5 | 21.1 | 17.3 | |||||||||||||||||
income-statement-row.row.net-income | 58.12 | 67.2 | 108.7 | 93.3 |
Често задавани въпроси
Какво е LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) общи активи?
LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) общите активи са 2528102214.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 576952643.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.095.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.095.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.051.
Какъв е общият приход на предприятието?
Общият приход е 0.064.
Каква е LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 67189706.000.
Какъв е общият дълг на фирмата?
Общият дълг е 26031519.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 261964435.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 365338610.000.